Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN105198935A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel chiral oxazoline palladium coordination compound patent CN105198935A offers high conversion in Henry reactions. Reliable supplier for pharmaceutical intermediates manufacturing.